UnitedHealth Group Incorporated — UNH
| Close Price | Market Cap | P/E Ratio | Forward P/E Ratio | Implied Growth* | Implied Forward Growth* | Dividend | P/B Ratio |
|---|---|---|---|---|---|---|---|
| $324.21 | $293.68B | 16.9 | 10.8 | 9.5% | 4.9% | $8.84 2.7% | 3.1 |
Revenue & Net Income
| Date | Revenue | Net Income | EPS | Revenue Change | Net Income Change | EPS Change | |
|---|---|---|---|---|---|---|---|
| 0 | 2021-12-31 | $287.6B | $17.3B | $18.33 | N/A | N/A | N/A |
| 1 | 2022-12-31 | $324.2B | $20.1B | $21.54 | 12.7% | 16.4% | 17.5% |
| 2 | 2023-12-31 | $371.6B | $22.4B | $24.22 | 14.6% | 11.2% | 12.4% |
| 3 | 2024-12-31 | $400.3B | $14.4B | $15.74 | 7.7% | -35.6% | -35.0% |
| 4 | TTM 2025-03-31 | $410.1B | $22.1B | $25.43 | 2.4% | 53.5% | 61.5% |
| 5 | Average | 9.3% | 11.4% | 14.1% |
EPS
Forecasts
Y/Y % Change
UNH Year-over-Year Growth
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Average | |
|---|---|---|---|---|---|---|---|
| Revenue Growth (%) | 12.7% | 14.6% | 7.7% | 11.9% | 2.8% | 9.9% | |
| Revenue Analysts (#) | 0 | 0 | 0 | 0 | 8 | 8 | |
| EPS Growth (%) | 16.4% | 11.2% | -35.6% | 2.6% | 8.6% | 0.6% | |
| EPS Analysts (#) | 0 | 0 | 0 | 0 | 10 | 10 |
Expenses
| Year | Revenue ($) | Cost of Revenue ($) | Facilities / D&A ($) |
|---|---|---|---|
| 2021 | $287.6B | $214.8B | $3.1B |
| 2022 | $324.2B | $241.1B | $3.4B |
| 2023 | $371.6B | $276.7B | $4.0B |
| 2024 | $400.3B | $306.8B | $4.1B |
| TTM | $422.8B | $330.5B | $4.2B |
| Year | Revenue Change (%) | Cost of Revenue Change (%) | Facilities / D&A Change (%) |
|---|---|---|---|
| 2022 | 12.71 | 12.24 | 9.57 |
| 2023 | 14.64 | 14.74 | 16.82 |
| 2024 | 7.71 | 10.87 | 3.20 |
| TTM | 5.63 | 7.72 | 3.12 |
No unmapped expenses.
Segment Performance
SEGMENTS v2025-09-09 · 2025-11-10 08:30 UTC — Units: $B. Rows list fiscal years (last 3 + TTM) with revenue and operating income for each segment; the final row shows the TTM revenue mix (operating income columns display “—” where mix is not applicable).
| Year | Prod Rev | Prod OI | Services Rev | Services OI | Total Rev | Total OI |
|---|---|---|---|---|---|---|
| 2022 | 149.7B | 0.00B | 100.2B | 0.00B | 249.9B | 0.00B |
| 2023 | 170.3B | 0.00B | 126.4B | 0.00B | 296.8B | 0.00B |
| 2024 | 200.9B | 0.00B | 134.4B | 0.00B | 335.3B | 0.00B |
| TTM | 216.1B | 0.00B | 140.6B | 0.00B | 356.7B | 0.00B |
| % of Total (TTM) | 60.6% | — | 39.4% | — | 100% | — |
SEGMENTS v2025-09-09 · 2025-11-10 08:30 UTC — Units: $B. Rows list fiscal years (last 3 + TTM) with revenue and operating income for each segment; the final row shows the TTM revenue mix (operating income columns display “—” where mix is not applicable).
| Year | Optum Health Rev | Optum Health OI | Optum Insight Rev | Optum Insight OI | Optum Rx Rev | Optum Rx OI | Optumhealth Rev | Optumhealth OI | Optuminsight Rev | Optuminsight OI | Optumrx Rev | Optumrx OI | Total Optum Rev | Total Optum OI | Unitedhealthcare Rev | Unitedhealthcare OI | Total Rev | Total OI |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | – | – | – | – | – | – | 0.00B | 6.03B | 0.00B | 3.59B | 0.00B | 4.44B | 0.00B | 14.1B | 0.00B | 14.4B | 0.00B | 42.5B |
| 2023 | – | – | – | – | – | – | 0.00B | 6.56B | 0.00B | 4.27B | 0.00B | 5.12B | 0.00B | 15.9B | 0.00B | 16.4B | 0.00B | 48.3B |
| 2024 | – | – | – | – | – | – | 0.00B | 7.77B | 0.00B | 3.10B | 0.00B | 5.84B | 0.00B | 16.7B | 0.00B | 15.6B | 0.00B | 49B |
| TTM | 0.00B | -5.38B | 0.00B | 0.75B | 0.00B | 0.22B | 0.00B | 7.77B | 0.00B | 3.10B | 0.00B | 5.84B | 0.00B | 12.3B | 0.00B | 9.67B | 0.00B | 34.3B |
Balance Sheet
| Metric | Value | |
|---|---|---|
| 0 | Total Assets | $308,573M |
| 1 | Cash | $28,596M |
| 2 | Total Liabilities | $203,789M |
| 3 | Total Debt | $79,193M |
| 4 | Total Equity | $94,724M |
| 5 | Debt to Equity Ratio | 0.84 |
EPS & Dividend
Valuation
| Share Price | Treasury Yield | Estimates | Fair Value (P/E) | Fair Value (P/S) | Current P/S | Current P/E |
|---|---|---|---|---|---|---|
| $302.01 | 4.4% | Nicks Growth: 8% Nick's Expected Margin: 6% FINVIZ Growth: 2% |
Nicks: 14 Finviz: 8 |
Nick's: 0.857 | 0.7 | 12.6 |
| Basis | Year | Nicks Valuation | Nicks vs Share Price | Finviz Valuation | Finviz vs Share Price |
|---|---|---|---|---|---|
| $25.43 EPS | TTM | $363.07 | 20.2% | $204.31 | -32.3% |
| $22.28 EPS | 2025 | $318.10 | 5.3% | $179.00 | -40.7% |
| $25.58 EPS | 2026 | $365.21 | 20.9% | $205.51 | -32.0% |
Implied Growth
| Average | Median | Std Dev | Current | Percentile | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | |
| Timeframe | ||||||||||
| 1 Year | 7.38% | 4.69% | 7.21% | 4.64% | 1.38% | 1.10% | 9.48% | 4.91% | 93.5% | 58.3% |
| 3 Years | 7.38% | 4.69% | 7.21% | 4.64% | 1.38% | 1.10% | 9.48% | 4.91% | 93.5% | 58.3% |
| 5 Years | 7.38% | 4.69% | 7.21% | 4.64% | 1.38% | 1.10% | 9.48% | 4.91% | 93.5% | 58.3% |
| 10 Years | 7.38% | 4.69% | 7.21% | 4.64% | 1.38% | 1.10% | 9.48% | 4.91% | 93.5% | 58.3% |